Back to dashboard

Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)

NATIONWIDE

The purpose of this FOA is to provide investigators with a mechanism to access contract research/medical organizations (CROs/CMOs) and subject matter experts (SMEs) within the NINDS Ultra-Rare Gene-based Therapy (URGenT) Network to support planning, manufacturing, and limited nonclinical therapeutic development efforts.

Categories
Apply Now

Don’t wait any longer! Easily apply for this grant to receive funds that are meant for you.

Apply Now
How to apply for grants?

Creating or growing your own venture can be a scary task — a task that often requires funding. It’s common when looking for funding to turn to banks and investors, but what if there was another option?

An option that has no cost.

Learn More